Patent · US Active

Phospholipid drug analogs

US9173935B2 · kind B2 · utility

20Cited by

14References

25Claims

0Family size

Assignee

Telormedix SA · CH

Inventors

Roberto Maj · Bioggio, CH
Franco Pattarino · Torino, IT
Emanuela Mura · Bioggio, CH
Alcide Barberis · Bioggio, CH

Key dates

Filing date	Apr 29, 2011
Grant date	Nov 3, 2015
Priority date	—
Expiry date	Apr 21, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided in some embodiments are compositions comprising a compound having a structure according to Formula A or Formula B:or a pharmaceutically acceptable salt, tautomer or hydrate thereof, where X2 is a bond or linker, X3 is bond or —PO4—, and X1, R1, R2, R3, and n are described herein. Also provided in some embodiments are methods for making and using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.